Last edition
News about "drug discovery"
TME Pharma Partners with aimed analytics for AI-Driven Drug Discovery and Optimization
This partnership supports TME Pharma's strategic plan, announced on December 4, 2024, by enhancing its capability profile for potential strategic partners.
Drug Discovery | 30/01/2025 | By Aishwarya
NVIDIA Teams Up with Industry Leaders to Accelerate Genomics and Drug Discovery
Healthcare leaders IQVIA, Illumina and Mayo Clinic, as well as Arc Institute, are using the latest NVIDIA technologies to develop solutions that will help advance human health.
Drug Discovery | 15/01/2025 | By Aishwarya
Acellera Rolls Out AceForce 1.0 to Advance Drug Discovery
AceForce 1.0 is a groundbreaking tool in computational chemistry and drug discovery, offering quantum-level accuracy by leveraging a proprietary training set of millions of quantum mechanical (QM) calculations.
Drug Discovery | 08/01/2025 | By Aishwarya
Axcelead DDP Signs Drug Discovery Service Deal with Astellas for Targeted Protein Degraders
Under the agreement, Axcelead DDP will support Astellas’ targeted protein degrader discovery utilizing DegLeadTM Platform and contribute to the generation of breakthrough new drug candidate compounds.
Drug Discovery | 27/12/2024 | By Aishwarya
Ono and Congruence to Generate Novel Small Molecule Correctors in Oncology Area
Under the terms of the agreement, Congruence will generate small molecule correctors by leveraging Congruence's proprietary drug discovery engine called, Revenir™.
Drug Discovery | 07/12/2024 | By Aishwarya
Parallel Fluidics Secures USD 7 Million Seed Round to Boost Microfluidic Development
The funding will help drive the growth of the company's on-demand design and manufacturing platform, expand its hardware and software solutions, and commercialize its new product, MV-2.
Drug Discovery | 08/11/2024 | By Aishwarya
Kvantify Launches New Computational Method for Drug Discovery
The method stands out significantly from other solutions on the market and is a strong addition to Kvantify's computational drug discovery platform, Koffee.
Drug Discovery | 14/10/2024 | By Aishwarya
Sanyou Bio Rolls Out Comprehensive Monkeypox Product Line
Developed using Sanyou Bio's proprietary 'over-trillion innovative antibody discovery' platform, the monoclonal antibodies span multiple species, including fully human, nano, and mouse antibodies.
Drug Discovery | 31/08/2024 | By Aishwarya
LabGenius Raises EUR 35 Million to Develop its ML-Driven Antibody Discovery Platform
LabGenius, a drug discovery company pioneering the use of machine learning for the discovery of novel therapeutic antibodies, has secured EUR 35 million in Series B financing round.
Drug Discovery | 23/05/2024 | By Aishwarya | 170
Evotec OAI Partners with Taisho Pharmaceutical to Accelerate Drug Discovery
Evotec OAI has entered into a drug discovery collaboration with Taisho Pharmaceutical Co., Ltd. Tokyo, Japan.
Drug Discovery | 25/04/2024 | By Aishwarya
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy